Crossmark

DPP9 sequesters the C terminus of NLRP1 to repress inflammasome activation

Crossref DOI link: https://doi.org/10.1038/s41586-021-03350-4

Published Online: 2021-03-17

Published Print: 2021-04-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hollingsworth, L. Robert https://orcid.org/0000-0002-4130-3580
Sharif, Humayun https://orcid.org/0000-0003-1308-3442
Griswold, Andrew R. https://orcid.org/0000-0003-2957-2355
Fontana, Pietro

Mintseris, Julian

Dagbay, Kevin B. https://orcid.org/0000-0001-7002-7207
Paulo, Joao A. https://orcid.org/0000-0002-4291-413X
Gygi, Steven P. https://orcid.org/0000-0001-7626-0034
Bachovchin, Daniel A. https://orcid.org/0000-0001-8210-1662
Wu, Hao https://orcid.org/0000-0002-7281-8579
License Information

Text and Data Mining valid from 2021-03-17

Version of Record valid from 2021-03-17
More Information

Article History

Received: 13 August 2020

Accepted: 9 February 2021

First Online: 17 March 2021

Competing interests

: H.W. is a co-founder of Ventus Therapeutics. The other authors declare no competing interests.